# Codeine Phosphate/Guaifenesin ER Tablet 30 mg/600 mg Steady State Clinical Study

> **NCT02572375** · PHASE1 · COMPLETED · sponsor: **Nexgen Pharma, Inc** · enrollment: 38 (actual)

## Conditions studied

- Cough

## Interventions

- **DRUG:** Codeine Phosphate/Guaifenesin ER Tablet
- **DRUG:** Codeine Phosphate/Guaifenesin IR Tablet

## Key facts

- **NCT ID:** NCT02572375
- **Lead sponsor:** Nexgen Pharma, Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-10
- **Primary completion:** 2014-11
- **Final completion:** 2015-01
- **Target enrollment:** 38 (ACTUAL)
- **Last updated:** 2017-03-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02572375

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02572375, "Codeine Phosphate/Guaifenesin ER Tablet 30 mg/600 mg Steady State Clinical Study". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT02572375. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*